Effect of withdrawal of pravastatin on biliary lipid composition in humans

Atherosclerosis

Volumn 123, Issue 1-2, 1996, Pages 133-137

  Muraca, Maurizio ^a   Baggio, Giovannella ^a   Vilei, Maria Teresa ^a   Martini, Scipione ^a   Cianci, Vito ^a   Crepaldi, Gaetano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Biliary cholesterol; HMG CoA reductase inhibitors; Lithogenic bile

Indexed keywords

ENDOGENOUS COMPOUND; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN;

ADULT; AGED; ARTICLE; CHOLELITHIASIS; CHOLESTEROL BILE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID BILE LEVEL; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STONE FORMATION;

EID: 0030006611     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05795-4     Document Type: Article

References (25)

1. Turley SD, Dietschy JM. The metabolism and excretion of cholesterol by the liver, In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA, (eds), The Liver: Biology and Pathobiology, 2nd ed, New York, Raven Press, 1987; 617-641.
2. Coleman R, Rahman K. Lipid flow in bile formation, Biochim Biophys Acta 1992;1125:113.
3. Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 1988;319:24.
4. Crepaldi G, Baggio G, Arca M, the Italian Multicenter Pravastatin Study I Group. Pravastatin vs. gemfibrozil in the treatment of primary hypercholesterolemia. Arch Intern Med 1991;151:146.
5. Illingworth DR. HMG CoA reductase inhibitors, Curr Opin Lipidol 1991;2:24.
6. Duane WC, Hunninghake DB, Freeman ML, Pooler PA, Schlasner LA, Gebhard RG. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gall bladder bile. Hepatology 1988;1147:1147.
7. Reihner E, Rudling M, Stahlberg D, Berglund L, Ewerth S, Bjorkhem I, Eirarsson K, Angelin B. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med 1990;323:224.
8. Hoogerbrugge-vd Linden N, De Rooy FWM, Jiansen H, van Blaukenstein M. Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolemia. Gut 1990;31:348.
9. Mitchell JC, Logan GM, Stone BG, Duane WC. Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans. J Lipid Res 1991;32:71.
10. Kempen HJM, De Lange J, Vos-Van Holstein MPM, Van Wachem P, Haringa R, Vonk RJ. Effect of ML-236B (compactin) on biliary excretion of bile salts and lipids, and on bile flow, in the rat. Biochim Biophys Acta 1984;794:435.
11. Muraca M, Baggio G, Miconi L, Vilei MT, Martini S, Gabelli C, Belluco C, Lise M, Crepaldi G. Acute effects of HMG-CoA reductase inhibitors on biliary lipids in patients with interrupted enterohepatic circulation. Eur J Clin Invest 1991;21:204.
12. Bilhartz LE, Spady DK, Dietschy JM. Inappropriate hepatic cholesterol synthesis expands the cellular pool of sterol available for recruitment by bile acids in the rat. J Clin Invest 1989;84:1181.
13. Hayashi K, Mitsuhide N, Kurushima H. et al. Effect of pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on hepatic cholesterol 7-α-hydroxylase, acyl-coenzyme A: cholesterol acyltransferase and bile lipid secretion in the hamster with intact enterohepatic circulation. Atherosclerosis 1994;111:183.
14. Grundy SM, Kalser SC. Highlights of the meeting on the prevention of gallstones. Hepatology 1987;7:946.
15. Muraca M, Vilei MT, Miconi L, Petrin P, Antoniutti M, Pedrazzoli S. A simple method for the determination of lipid composition of human bile. J Lipid Res 1991;30:371.
16. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466.
17. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945.
18. Edwards PA, Fogelman AM. Cellular enzymes of cholesterol metabolism. Curr Opin Lipidol 1990;1:136.
19. Okolicsanyi L, Lirussi F, Strazzabosco M, Jemmolo RM, Orlando R, Nassuato G, Muraca M, Crepaldi G. The effect of drugs on bile flow and composition: an overview. Drugs 1986;31:430.
20. Smit JW, van Epercum KJ, Stolk MF, Geerdink RA, Cluysenaer OJ, Erkelens DW, van Berge Henegouwen GP. Successful dissolution of cholesterol gallstones during treatment with pravastatin. Gastroenterology 1992;103:1068.
21. Saunders KD, Cates JA, Abedin MZ, Roslyn JJ. Lovastatin and gallstone dissolution: a preliminary study. Surgery 1993;113:28.
22. Danielsson H, Einersson K, Johansson G. Effect of biliary drainage on individual reactions in the conversion of cholesterol to taurocholic acid. Eur J Biochem 1967;2:44.
23. Grundy SM, Ahrens Jr EH, Salen G. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med 1971;78:94.
24. Scheibner J, Fuchs M, Schiemann M, Tauber G, Hormann E, Stange EF. Bile acid synthesis from newly synthesized vs. preformed cholesterol precursor pools in the rat. Hepatology 1993;17:1095.
25. Scheibner J, Fuchs M, Hormann E, Tauber G, Stange EF. Biliary cholesterol secretion and bile acid formation in the hamster: the role of newly synthesized cholesterol. J Lipid Res 1994;35:690.